Zhen-chao DU
YOU?
Author Swipe
View article: Burden of aortic aneurysm in China from 1990 to 2021: A comparative analysis with G20 countries based on the Global Burden of Disease Study 2021
Burden of aortic aneurysm in China from 1990 to 2021: A comparative analysis with G20 countries based on the Global Burden of Disease Study 2021 Open
AA remains a serious threat to public health in China, especially for the male and elderly population. Smoking, high systolic blood pressure, and high body-mass index were major attributable risk factors for AA in China. Targeted and cost-…
View article: FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer Open
Background Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to …
View article: FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer 
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer Open
Background: Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to…
View article: FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer Open
Background: Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to…
View article: FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer Open
Background Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers tha…